Drug Profile
Research programme: metabotropic glutamate receptor 4 modulators - Bristol-Myers Squibb/Vanderbilt University
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Vanderbilt University
- Class
- Mechanism of Action Metabotropic glutamate receptor 4 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Parkinson's-disease in USA
- 21 Sep 2012 Early research in Parkinson's disease in USA (unspecified route)